Search Result "meglitinide analogues"
Pharmacotherapy in Type 2 Diabetes: A Functional Schema for Drug Classification
Journal: Current Diabetes Reviews
Volume: 8 Issue: 4 Year: 2012 Page: 257-267
Author(s): Janet B. McGill
Diabetes Beyond Insulin: Review of New Drugs for Treatment of Diabetes Mellitus
Journal: Current Drug Discovery Technologies
Volume: 4 Issue: 1 Year: 2007 Page: 39-47
Author(s): Pankaj Modi
Therapeutic Management of Type 2 Diabetes: The Nitric Oxide Axis
Ebook: The Role of Nitric Oxide in Type 2 Diabetes
Volume: 1 Year: 2022
Author(s): Jennifer L. OâConnor
Doi: 10.2174/9789815079814122010013
The Effects of Medications Used for the Management of Diabetes and Obesity on Postprandial Lipid Metabolism
Journal: Current Diabetes Reviews
Volume: 4 Issue: 4 Year: 2008 Page: 340-356
Author(s): Ioanna Eleftheriadou, Pinelopi Grigoropoulou, Nicholas Katsilambros, Nicholas Tentolouris
Pharmacology and Chemistry of Diabetes mellitus and Antidiabetic Drugs: A Critical Review
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2010 Page: 4405-4423
Author(s): Ganesh R. Kokil, Prarthana V. Rewatkar, Arunima Verma, Suresh Thareja, Suresh R. Naik
Can Antidiabetic Drugs Improve Male Reproductive (Dys)Function Associated with Diabetes?
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 22 Year: 2019 Page: 4191-4222
Author(s): R.S. Tavares,S. Escada-Rebelo,M.I. Sousa,A. Silva,J. Ramalho-Santos,S. Amaral
Pharmacological Management of Type 2 Diabetes Mellitus: An Update
Journal: Current Diabetes Reviews
Volume: 7 Issue: 6 Year: 2011 Page: 392-405
Author(s): Samer El-Kaissi, Suphia Sherbeeni
Endocrine Therapies and QTc Prolongation
Journal: Current Drug Safety
Volume: 5 Issue: 1 Year: 2010 Page: 79-84
Author(s): Claudio Daniel Gonzalez, Martha de Sereday, Isaac Sinay, Silvina Santoro
Efficacy and Cardiovascular Safety of Antidiabetic Medications
Journal: Current Drug Safety
Volume: 16 Issue: 2 Year: 2021 Page: 115-121
Author(s): Joseph M. Pappachan
Diabetes and Antidiabetic Drugs
Ebook: Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems
Volume: 3 Year: 2024
Author(s):
Doi: 10.2174/9789815179729124030009